0.8 ML adalimumab 50 MG/ML Injection [Humira]

Known as: 0.8 ML Humira 40 MG Injection, ADALIMUMAB 40 mg in 0.8 mL SUBCUTANEOUS INJECTION, SOLUTION [Humira], 0.8 ML Humira 50 MG/ML Injection 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
A biosimilar is a biological medicinal product that is highly similar to an authorized biological product in terms of quality… (More)
Is this relevant?
2017
2017
Biosimilars are biological products that are highly similar to existing products approved by health authorities. Demonstration of… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2017
2017
The management of chronic inflammatory diseases, such as inflammatory bowel disease, psoriasis, and rheumatoid arthritis has… (More)
Is this relevant?